# FDA Inspection 1215034 - Granules Pharmaceuticals Inc. - August 03, 2023

Source: https://www.globalkeysolutions.net/records/fda_inspections/granules-pharmaceuticals-inc/f3a55b08-5f7e-4034-af92-ce1868eb2476/
Source feed: FDA_Inspections

> FDA Inspection 1215034 for Granules Pharmaceuticals Inc. on August 03, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1215034
- Company Name: Granules Pharmaceuticals Inc.
- Inspection Date: 2023-08-03
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1274604 - 2025-06-27](https://www.globalkeysolutions.net/api/records/fda_inspections/granules-pharmaceuticals-inc/c26a7eea-057c-452e-9446-c4409110a57b/)
- [FDA Inspection 1225087 - 2023-12-15](https://www.globalkeysolutions.net/api/records/fda_inspections/granules-pharmaceuticals-inc/45371d19-7a67-4bab-ae38-48217349ea87/)
- [FDA Inspection 1175097 - 2022-07-22](https://www.globalkeysolutions.net/api/records/fda_inspections/granules-pharmaceuticals-inc/d7966f15-715b-4405-88ac-c9e7d0d9e64c/)
- [FDA Inspection 1035023 - 2017-12-08](https://www.globalkeysolutions.net/api/records/fda_inspections/granules-pharmaceuticals-inc/365993a1-7a71-474c-9726-9ded32a3e0ca/)

Company: https://www.globalkeysolutions.net/companies/granules-pharmaceuticals-inc/fa93bf3f-822e-47be-9e47-59b1c5446629

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c